Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of low IGF-1 syndrome in chronic heart failure with Saizen
2009-017011-16Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF), insulin-like growth factor 1 deficiency and growth hormone deficiency (GHD) comparing Saizen with Placebo (2 arms). Primary endpoint: Increase in peak VO2. Started May 2011; status: completed.
02
Drugs
somatropin
03
Conditions
chronic heart failure (CHF)insulin-like growth factor 1 deficiencygrowth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2009-017011-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017011-16.